News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
EU Approves Purchase of Respironics, Inc. by Royal Philips Electronics N.V. for $5.1B
March 5, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BRUSSELS, March 5 (Reuters) - Philips won permission from the European Commission on Wednesday to buy U.S. sleep therapy products maker Respironics Inc for $5.1 billion, its largest deal to date in the fast-growing health-care sector.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Obesity
Lilly Inks Deal Worth up to $870M To Develop Long-Acting GLP-1 Obesity Drugs
June 4, 2025
·
2 min read
·
Nick Paul Taylor
Venture capitalists
Boom, Bust and Recover: What Happens Next as Biotech VC Cycle Resets
June 4, 2025
·
3 min read
·
Annalee Armstrong
Editorial
The Decadent Show of Data at ASCO25
June 3, 2025
·
2 min read
·
Dan Samorodnitsky
Obesity
Amid Rough Waters, Regeneron Puts Nearly $2B on the Line For Chinese Obesity Drug
June 2, 2025
·
2 min read
·
Dan Samorodnitsky